輸入代號或公司名稱後按 Enter
4747

強生*

-0.70 (-2.86%)最後更新 2026-09-16
台灣 · 上櫃 · 生技醫療業
23.8080成交張數25.00本益比1.28股價淨值比2.14%殖利率2026-09-16資料日期

綜合損益表公開資訊觀測站申報原值 · 年度(第 4 季累計) · 每一格 = 該科目 ÷ 營業收入

營業收入2025570年增 -6.8%
毛利率202540.1%最新一期
營業利益率202512.9%最新一期
每股盈餘20251.19年增 -36.4%
會計項目走勢2016201720182019202020212022202320242025
營業收入合計100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%
營業成本合計54.3%57.1%57.1%55.0%54.7%58.2%58.7%59.7%59.4%59.9%
營業毛利(毛損)45.7%42.9%42.9%45.0%45.3%41.8%41.3%40.3%40.6%40.1%
營業毛利(毛損)淨額45.7%42.9%42.9%45.0%45.3%41.8%41.3%40.3%40.6%40.1%
推銷費用18.2%17.9%17.7%18.0%18.0%18.1%16.9%16.6%16.2%17.8%
管理費用6.5%6.3%6.2%6.2%6.4%6.4%5.0%4.6%5.0%6.6%
研究發展費用2.5%1.8%2.3%2.3%3.1%2.2%2.7%2.8%3.4%2.8%
預期信用減損損失(利益)0.0%0.0%-0.1%0.0%0.2%0.0%-0.0%-0.0%
營業費用合計27.2%26.0%26.2%26.5%27.4%26.6%24.8%24.0%24.5%27.2%
營業利益(損失)18.5%16.8%16.7%18.5%17.9%15.1%16.5%16.3%16.1%12.9%
利息收入0.2%0.1%0.1%1.0%2.2%2.4%
其他收入0.6%1.5%0.6%0.6%0.1%0.2%0.1%0.1%0.4%0.7%
其他利益及損失淨額-0.1%-0.1%-0.0%-0.0%-0.0%-0.2%-0.0%-0.0%-0.2%-4.2%
財務成本淨額0.0%0.2%0.3%0.2%0.8%0.6%0.7%
營業外收入及支出合計0.5%1.4%0.5%0.6%0.1%-0.1%-0.1%0.3%1.7%-1.7%
稅前淨利(淨損)19.0%18.2%17.2%19.1%18.1%15.1%16.5%16.6%17.8%11.1%
所得稅費用(利益)合計2.8%3.0%3.3%4.0%3.1%3.1%3.4%3.5%4.0%1.7%
繼續營業單位本期淨利(淨損)16.2%15.2%13.9%15.2%15.0%11.9%13.1%13.1%13.8%9.4%
本期淨利(淨損)16.2%15.2%13.9%15.2%15.0%11.9%13.1%13.1%13.8%9.4%
確定福利計畫之再衡量數-0.0%0.0%0.3%-0.1%0.6%-0.5%0.4%-0.7%0.7%-0.4%
透過其他綜合損益按公允價值衡量之權益工具投資未實現評價損益-1.8%-0.7%-0.5%0.2%-0.0%0.1%-0.3%0.3%
不重分類至損益之項目:-0.8%0.2%-0.3%0.4%-0.6%0.4%-0.0%
其他綜合損益(淨額)-0.0%0.0%-1.5%-0.8%0.2%-0.3%0.4%-0.6%0.4%-0.0%
本期綜合損益總額16.1%15.2%12.4%14.3%15.2%11.6%13.5%12.5%14.2%9.3%
母公司業主(淨利∕損)15.2%15.0%11.9%13.1%13.1%13.8%9.4%
母公司業主(綜合損益)14.3%15.2%11.6%13.5%12.5%14.2%9.3%
基本每股盈餘0.5%0.5%0.5%0.5%0.5%0.4%0.4%0.4%0.3%0.2%
稀釋每股盈餘0.5%0.5%0.5%0.5%0.5%0.4%0.4%0.4%0.3%0.2%

金額為公司申報原值除以一千(百萬元,四捨五入),每股金額為元。年度為第 4 季的年初至今累計數。走勢條是歷史各期的相對大小,藍為正、綠為負。年增以去年同期為基期,基期非正數或變動超過十倍時不列。 權益變動表在申報資料分頁。